403 related articles for article (PubMed ID: 11032974)
1. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
[TBL] [Abstract][Full Text] [Related]
2. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
[TBL] [Abstract][Full Text] [Related]
3. Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex.
Usun Y; Eybrard S; Meyer F; Louilot A
Behav Brain Res; 2013 Nov; 256():229-37. PubMed ID: 23958806
[TBL] [Abstract][Full Text] [Related]
4. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
Abi-Dargham A; Kegeles LS; Zea-Ponce Y; Mawlawi O; Martinez D; Mitropoulou V; O'Flynn K; Koenigsberg HW; Van Heertum R; Cooper T; Laruelle M; Siever LJ
Biol Psychiatry; 2004 May; 55(10):1001-6. PubMed ID: 15121484
[TBL] [Abstract][Full Text] [Related]
5. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
Abi-Dargham A; Gil R; Krystal J; Baldwin RM; Seibyl JP; Bowers M; van Dyck CH; Charney DS; Innis RB; Laruelle M
Am J Psychiatry; 1998 Jun; 155(6):761-7. PubMed ID: 9619147
[TBL] [Abstract][Full Text] [Related]
6. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
Laruelle M; Abi-Dargham A; van Dyck CH; Gil R; D'Souza CD; Erdos J; McCance E; Rosenblatt W; Fingado C; Zoghbi SS; Baldwin RM; Seibyl JP; Krystal JH; Charney DS; Innis RB
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9235-40. PubMed ID: 8799184
[TBL] [Abstract][Full Text] [Related]
7. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.
Moghaddam B; Adams B; Verma A; Daly D
J Neurosci; 1997 Apr; 17(8):2921-7. PubMed ID: 9092613
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression.
Parsey RV; Oquendo MA; Zea-Ponce Y; Rodenhiser J; Kegeles LS; Pratap M; Cooper TB; Van Heertum R; Mann JJ; Laruelle M
Biol Psychiatry; 2001 Sep; 50(5):313-22. PubMed ID: 11543733
[TBL] [Abstract][Full Text] [Related]
9. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
Anand A; Verhoeff P; Seneca N; Zoghbi SS; Seibyl JP; Charney DS; Innis RB
Am J Psychiatry; 2000 Jul; 157(7):1108-14. PubMed ID: 10873919
[TBL] [Abstract][Full Text] [Related]
10. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
[TBL] [Abstract][Full Text] [Related]
11. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
Aalto S; Hirvonen J; Kajander J; Scheinin H; Någren K; Vilkman H; Gustafsson L; Syvälahti E; Hietala J
Psychopharmacology (Berl); 2002 Dec; 164(4):401-6. PubMed ID: 12457270
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.
Pogarell O; Koch W; Karch S; Dehning S; Müller N; Tatsch K; Poepperl G; Möller HJ
Pharmacopsychiatry; 2012 May; 45 Suppl 1():S36-41. PubMed ID: 22565233
[TBL] [Abstract][Full Text] [Related]
13. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M
Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701
[TBL] [Abstract][Full Text] [Related]
14. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
[TBL] [Abstract][Full Text] [Related]
15. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
Adams BW; Bradberry CW; Moghaddam B
Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
[TBL] [Abstract][Full Text] [Related]
16. Modulation of striatal dopamine release by glycine transport inhibitors.
Javitt DC; Hashim A; Sershen H
Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
[TBL] [Abstract][Full Text] [Related]
17. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
[TBL] [Abstract][Full Text] [Related]
18. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.
Balla A; Koneru R; Smiley J; Sershen H; Javitt DC
Neuropsychopharmacology; 2001 Aug; 25(2):157-64. PubMed ID: 11425499
[TBL] [Abstract][Full Text] [Related]
19. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
[TBL] [Abstract][Full Text] [Related]
20. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
